TideZ of Discovery
BPC-157 / TB-500 Blend 5/5mg
Lyophilized two-component research blend of BPC-157 and thymosin beta-4 fragment. Third-party tested. Batch COA included. Not for human or animal consumption, injection, or any clinical use.
What is in the vial
Labeled identity
Pep TideZ 808 BPC/TB 5/5. Vertical mark: RESEARCH USE ONLY.
Assayed content
Label claim 5/5 mg. Assay: BPC-157 4.56 mg and thymosin beta-4 fragment 4.83 mg (9.39 mg total).
Intended research context
Two-component blend for laboratory studies of body-protection and actin-binding peptide fragments. Not supplied for personal administration.
Molecular identity
Reference structures for catalog framing, COA matching, and laboratory documentation. For Research Use Only. Not for human consumption.
BPC-157
Role. Synthetic pentadecapeptide research fragment.
Sequence. Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Molecular formula. C62H98N16O22
Molecular weight. ≈ 1419.5 Da
TB-500 / Tβ4 fragment
Role. Actin-binding peptide fragment used as the TB-500 research component.
Sequence. Leu-Lys-Lys-Thr-Glu-Thr-Gln (common research fragment)
Molecular formula. C38H68N10O14
Molecular weight. ≈ 889 Da
Framing: two-component regenerative-pathway research blend. Component % values on the COA are relative peak shares of the blend, not standalone vial purity.
Purity & COA documentation
Figures from the third-party Certificate of Analysis for BPC/TB 5/5. This report is page 1 of 1 (purity). No separate endotoxin page was provided in the current file set.
| Test | Method / source | Result | Status |
|---|---|---|---|
| Total purity | Peptide panel (TM-13) | 99.90% | Reported |
| BPC-157 content | mg/unit on COA | 4.56 mg/unit | Reported |
| Thymosin beta-4 content | mg/unit on COA | 4.83 mg/unit | Reported |
| Total peptide mass | Sum of analytes | 9.39 mg/unit | Reported |
| Endotoxin | Not on this COA page | — | Not on file |
| Matrix / presentation | COA header | Peptide · vial | As reported |
Matching purity COA ships with the vial. Supplier identity is redacted for their protection. Endotoxin documentation can be added when the second page is issued.
Label claim remains 5/5 mg; assayed mass on this batch is 4.56 / 4.83 mg. The laboratory header lists sample type as “Vial (Injectable).” That is the lab’s matrix field only. This product is sold as Research Use Only and is not offered for injection or any human use. Supplier identity is redacted for their protection. Unredacted laboratory identifiers are available to qualified research purchasers upon request.
COA page 1 — purity
99.90% total purity. BPC-157 4.56 mg. Tβ4 4.83 mg. Total 9.39 mg.
Shipping from Honolulu
Protected pack-out
Insulated packaging with ice packs as standard for this lyophilized research material. Discrete, trackable U.S. shipping from Oahu.
Threshold
Free shipping on qualifying orders of $100 or more, consistent with the current Pep TideZ 808 store policy.
Documents in the box
Vial, RUO labeling, and the matching COA for the shipped batch, supplier identity redacted. This batch COA is a single purity page; a separate endotoxin page was not included in the current file set.
Research buyer FAQ
Is this for human use?
No. All Pep TideZ 808 products are Research Use Only. They are not intended for human or animal consumption, injection, diagnostic use, therapeutic use, or any form of personal administration.
Who may purchase?
Purchasers must be at least 21 and represent that they are a qualified researcher, laboratory professional, or authorized representative of a legitimate research organization, and that the material will be used only for lawful laboratory research.
What testing is provided?
This batch: 99.90% total purity, BPC-157 4.56 mg, thymosin beta-4 fragment 4.83 mg, combined 9.39 mg. Purity-page COA ships with the vial. Endotoxin page not in the current documentation set.